Recherche
-
DPP-4 Inhibitors in Combination with Lipid-Lowering Agents and Risk of Serious Muscular Injury: A Nested Case-Control Study in a Nationwide Cohort of Patients with Type 2 Diabetes Mellitus
(Drug Safety. vol. 43, n° 8, pp. 767-774, 2020)Article de revue -
An Automated System Combining Safety Signal Detection and Prioritization from Healthcare Databases: A Pilot Study
(Drug Safety. vol. 41, n° 4, pp. 377-387, 2018-04)Article de revue -
High prevalence of spin was found in pharmacovigilance studies usingdisproportionality analyses todetectsafetysignals: a meta-epidemiologicalstudy: Spin in pharmacovigilance disproportionality analyses
(Journal of Clinical Epidemiology. vol. 138, pp. 73-79, 2021-06-26)Article de revue -
Pharmacovigilance of sodium-glucose co-transporter-2 inhibitors: What a clinician should know on disproportionality analysis of spontaneous reporting systems
(Nutrition, metabolism, and cardiovascular diseases. vol. 28, n° 6, pp. 533-542, 2018-06)Article de revue -
The economic burden of preventable adverse drug reactions: a systematic review of observational studies
(Expert Opinion on Drug Safety. vol. 17, n° 7, pp. 681-695, 2018-07)Article de revue -
Will the future of pharmacovigilance be more automated?
(Expert Opinion on Drug Safety. vol. 22, n° 7, pp. 541-548, 2023-07-01)Article de revue -
Antipsychotics and risk of QT prolongation: a pharmacovigilance study
(Psychopharmacology. vol. 240, pp. 199-202, 2022-12-14)Article de revue -
Risk of Motor Vehicle Accidents Related to Sleepiness at the Wheel: A Systematic Review and Meta-Analysis
(Sleep. vol. 41, n° 7, 2018-07-01)Article de revue -
Type I interferons as the potential mechanism linking mRNA COVID-19 vaccines to Bell's palsy
(Thérapie, 2021-04-02)Article de revue -
Interest and challenges of pharmacoepidemiology for the study of drugs used in diabetes
(Therapie. vol. 74, n° 2, pp. 255-260, 2019-04)Article de revue